Masterka® is FCI innovative solution for treatment of congenital nasolacrimal duct obstruction resistant to probing. Especially indicated for children, this intubation has no metallic probe or suture attached to it and is therefore not pulled out of the nose. The insertion procedure is easy and less traumatic than with conventional intubation sets.


I agree that the personal data within the contact form (First Name, Last Name, Country, Email Address) is processed by FCI S.A.S. and other companies of the Zeiss Group for the purpose of my request. This consent can be revoked at any time by email:

Related Resources


Oculoplastics Product Catalog

August 5, 2019 – 12.98 MB PDF

FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery, thanks to a wide range of innovative ophthalmic devices such as self-retaining intubation sets, lacrimal balloon catheter, injectable monocanalicular intubation, permanent punctal plugs, eyelids and orbital implants.


March 27, 2020

File Size & Type

4.08 MB PDF